Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com 0 Related Posts CoTec to Host Investor Update January 14, 2026 Sankamap Provides Update on Late Filing of Financial Statements and Extension of MCTO January 14, 2026 Cobalt Market 2025 Year-End Review January 14, 2026
Sankamap Provides Update on Late Filing of Financial Statements and Extension of MCTO January 14, 2026